Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Novo Nordisk hit hard as U.S. rebuffs insulin drug
Yahoo/Reuters
Mon, 02/11/13 - 08:15 am
Tags:
insulin, Novo Nordisk, diabetes, FDA, Tresiba
Alas, Hamlet! A Diabetes Drugmaker to Renew the Faith
Motley Fool
Tue, 02/5/13 - 10:49 am
Tags:
diabetes, Novo Nordisk
Danish drug maker Novo Nordisk in $1 billion net profit on strong sales of insulins
Yahoo/AP
Thu, 01/31/13 - 10:40 am
Tags:
Novo Nordisk, earnings
Novo Nordisk A/S Reaches New 52-Week High (NVO)
The Street
Wed, 01/30/13 - 06:12 pm
Tags:
Novo Nordisk, 52 week high, stock
Eli Lilly May Have The Best Chance At Keeping The Momentum Going
Seeking Alpha
Wed, 01/30/13 - 04:16 pm
Tags:
Eli Lilly, Bristol-Myers Squibb, Novo Nordisk, Pfizer, Sanofi
Big Pharma Diabetes Face-Off
The Motley Fool
Sat, 01/19/13 - 11:07 am
Tags:
Pharma, diabetes, Bristol-Myers Squibb, Astra Zeneca, Novo Nordisk, GlaxoSmithKline
Analysis: Drug industry bets on new blockbusters in 2013
Reuters
Tue, 01/15/13 - 11:37 am
Tags:
Roche, GlaxoSmithKline, Eli Lilly, Biogen Idec, Gilead Sciences, Novo Nordisk
Japan gives initial OK to Novo's insulin combo, Ryzodeg
Fierce Pharma
Thu, 12/27/12 - 10:32 pm
Tags:
Japan, Novo Nordisk, Ryzodeg
The Next Wave of Diabetes Dominance
Motley Fool
Wed, 12/12/12 - 08:11 am
Tags:
diabetes, Bayer, Sanofi, Novo Nordisk, Abbott Labs, Bristol-Myers Squibb
This Top Big Pharma Stock Just Got an Upgrade
Motley Fool
Sat, 12/8/12 - 11:31 am
Tags:
Novo Nordisk
Glaxo Doubts GLP-1s Would Be Cleared as Drugs for Obesity
Bloomberg
Tue, 12/4/12 - 11:55 am
Tags:
GSK, GLP-1 agonist, obesity, diabetes, albiglutide, Victoza, Novo Nordisk
Novo Nordisk says new data show Victoza advantage
Reuters
Tue, 11/27/12 - 10:36 am
Tags:
diabetes, Novo Nordisk, Victoza, Merck, Amylin
Novo Nordisk A/S: Catching The Increasing Diabetes Trend
Seeking Alpha
Tue, 11/20/12 - 11:27 am
Tags:
diabetes, Novo Nordisk, Bristol-Myers Squibb, Eli Lilly, Sanofi
Teva Is Still Healthier Than Its Big Pharma Peers
Seeking Alpha
Thu, 11/15/12 - 10:47 am
Tags:
Teva, AstraZeneca, Bristol-Myers Squibb, GSK, JNJ, Merck, Novo Nordisk, Novartis, Pfizer, Sanofi
Degludec And Liraglutide: 2 Drivers Of Novo Nordisk's Growth
Seeking Alpha
Tue, 11/13/12 - 12:11 pm
Tags:
diabetes, degludec, liraglutide, Novo Nordisk, Victoza
This Week in Biotech: Part 1
Motley Fool
Sun, 11/11/12 - 09:17 am
Tags:
Novartis, Novo Nordisk, Corcept Therapeutics, Biomarin, Sequenom
Novo Aims for Tresiba U.S. Approval in First Half of 2013
Bloomberg
Fri, 11/9/12 - 11:07 am
Tags:
Novo Nordisk, Tresiba, diabetes, degludec, insulin
FDA panel recommends approval of Novo degludec insulin
Reuters
Thu, 11/8/12 - 09:52 pm
Tags:
FDA, advisory panels, Novo Nordisk, degludec, insulin
Why Investors Are Voting Against Novo Nordisk
Motley Fool
Wed, 11/7/12 - 11:55 am
Tags:
Novo Nordisk, FDA, advisory panels, Tresiba, insulin
5 Companies Dominating Diabetes
Motley Fool
Tue, 11/6/12 - 04:21 pm
Tags:
diabetes, AstraZeneca, Bristol-Myers Squibb, Sanofi, Novo Nordisk, MannKind

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.